Garri Zmudze, Sergey Jakimov, and Ilya Suharenko launch a new fund for longevity research: LongeVC.
Longevity-focused research and technologies have the potential to revolutionize healthcare, extend healthy lifespans, and address the challenges posed by an aging population. However, traditional investment models often overlook or undervalue longevity-focused companies and projects due to their unique characteristics and longer timeframes for returns on investment. LongeVC launched in 2020 to support cutting-edge, early-stage research in the field.
LongeVC's investment can help bridge the funding gap by providing targeted financial support to companies and projects in the longevity space. Its investment strategies are based around a deep understanding of the field, identification of high-potential opportunities, and a long-term outlook that aligns with the goals and timelines of longevity research and development.
Read the full piece in Longevity.Technology here.
